Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Methylene Blue Injection in Healthy Volunteers
NCT02478281Phase 1Completed
- Sponsor
- American Regent, Inc.
- Start
- Oct 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of methylene blue in methemoglobinemia (MetHb), sponsored by American Regent, Inc. Primary endpoints: Area Under the Curve From Time Zero to the Time of Last Quantifiable Concentration, Area Under the Curve From Time Zero Extrapolated to Infinity and 5 more. Started Oct 2012; status: completed.
02
Drugs
methylene blue
03
Conditions
methemoglobinemia (MetHb)
Beyond the preview
Go deeper on NCT02478281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478281.